Officials have placed a two-year limit on Wegovy, and although no restriction has been put on how long NHS patients can stay on Mounjaro, the NHS is going to roll ... off-label for weight-loss.

Following a second day of stock market gains, investors looked forward to earnings reports from Eli Lilly and Amazon.

Bank of America analyst Tim Anderson agreed and noted it doesn't assume a ramp-up in the rate of new Mounjaro and Zepbound ... around $2300 and starting to roll beneath its 50-day.

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion. The drugmaker ...

Your doctor may also prescribe Mounjaro off-label for weight management. (Off-label use of a drug is when your doctor prescribes a medication for a different use than what it was approved for.) ...